Search results
Results from the WOW.Com Content Network
As of October 2020, Operation Warp Speed had spent less than $1 billion to support the development and manufacturing of three monoclonal antibody treatments, versus almost $10 billion on six vaccines. [53] Regeneron was to receive $450 million to develop and supply a monoclonal antibody drug, according to a government announcement on July 7, 2020.
In May 2020, Perna was named Chief Operating Officer (COO) of the White House's Operation Warp Speed effort to quickly develop a COVID-19 vaccine. [11] [12] In June 2020, he was nominated to continue serving as an Army general in the position of COO, and was confirmed the next month by the Senate. [3]
He co-chaired the Biden-Harris transition’s COVID-19 Advisory Board from November 2020 to January 2021 and was the head of Operation Warp Speed, the U.S. government program to accelerate the development of COVID-19 vaccines and other treatments, from January to February 2021. [1] [2]
Launched in April 2020, Operation Warp Speed drew on $14 billion in federal investment to foster public-private partnerships with pharmaceutical companies. While Pfizer ...
"It was a planning error, and I am responsible," said General Gustave Perna, the chief operating officer of Operation Warp Speed.
For premium support please call: 800-290-4726 more ways to reach us
The federal government managed the development of several vaccines for the virus through Operation Warp Speed in 2020. Distribution of the vaccines was overseen by the Biden administration during 2021, during which time many pandemic measures were ended. The national emergency related to the pandemic was ended by a bipartisan resolution of ...
President Donald Trump signs an executive order during an Operation Warp Speed vaccine summit at the White House in Washington, D.C., U.S., on Tuesday, Dec. 8, 2020.